Sotac Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 18.09 | 13.44 | 16.84 |
| Operating Expense | 16.09 | 10.91 | 14 |
| Net Profit | 0.86 | 1.25 | 1.38 |
| Net Profit Margin | 4.75 | 9.30 | 8.19 |
| Earning Per Share | 0.78 | 1.13 | 1.25 |
| EBIDTA | 2.03 | 2.55 | 2.91 |
| Effective Tax Rate | 16.50 | 17.39 | 19.37 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 18.09 |
| Operating Expense | 16.09 |
| Net Profit | 0.86 |
| Net Profit Margin | 4.75 |
| Earning Per Share | 0.78 |
| EBIDTA | 2.03 |
| Effective Tax Rate | 16.50 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 62.38 | 67.11 | 57.98 |
| Operating Expenses Annual | 54.70 | 56.91 | 49.77 |
| Operating Profit Annual | 10.06 | 11.28 | 8.45 |
| Interest Annual | 1.17 | 1.01 | 0.86 |
| Depreciation | 2.47 | 2.51 | 1.63 |
| Net Profit Annual | 4.77 | 5.75 | 4.50 |
| Tax Annual | 1.64 | 2.01 | 1.47 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 62.38 |
| Operating Expenses Annual | 54.70 |
| Operating Profit Annual | 10.06 |
| Interest Annual | 1.17 |
| Depreciation | 2.47 |
| Net Profit Annual | 4.77 |
| Tax Annual | 1.64 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.64 | 9.60 | 0.03 |
| Cash Flow from Operations | -6.08 | -19.75 | 8.54 |
| Cash Flow from Investing | -1.89 | -12.53 | -10.93 |
| Cash Flow from Financing | 7.78 | 23.32 | 11.97 |
| Cash Flow at the End | 0.45 | 0.64 | 9.60 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.64 |
| Cash Flow from Operations | -6.08 |
| Cash Flow from Investing | -1.89 |
| Cash Flow from Financing | 7.78 |
| Cash Flow at the End | 0.45 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 16.13 | 16.82 | 14.64 |
| PBIT Margin (%) | 12.17 | 13.08 | 11.83 |
| PBT Margin (%) | 1.78 | 0.25 | -1.33 |
| Net PROFIT Margin (%) | 7.65 | 8.57 | 7.76 |
| Return On Networth / Equity (%) | 9.42 | 16.60 | 32.04 |
| Return On Networth /Employed (%) | 11.41 | 19.24 | 29.73 |
| Return On Assets (%) | 7.19 | 12.59 | 19.48 |
| Total Debt / Equity (X) | 0.31 | 0.32 | 0.64 |
| Asset Turnover Ratio (%) | 0.94 | 1.47 | 2.51 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 16.13 |
| PBIT Margin (%) | 12.17 |
| PBT Margin (%) | 1.78 |
| Net PROFIT Margin (%) | 7.65 |
| Return On Networth / Equity (%) | 9.42 |
| Return On Networth /Employed (%) | 11.41 |
| Return On Assets (%) | 7.19 |
| Total Debt / Equity (X) | 0.31 |
| Asset Turnover Ratio (%) | 0.94 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 16.66 | 17.67 | 14.09 |
| Total Current Assets Annual | 54.90 | 46.75 | 36.61 |
| Non Current Assets Annual | 30.40 | 29.34 | 18.18 |
| Total Shareholders Funds Annual | 53.03 | 48.27 | 20.99 |
| Total Assets Annual | 85.29 | 76.09 | 54.78 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 16.66 |
| Total Current Assets Annual | 54.90 |
| Non Current Assets Annual | 30.40 |
| Total Shareholders Funds Annual | 53.03 |
| Total Assets Annual | 85.29 |
EPS (INR)
Expected
0.42
Reported
0.42
Surprise
0.00%
Jun 2024
EPS beaten by 0.00%
Mar 2024
EPS beaten by 0.76%
Dec 2023
EPS beaten by 0.68%
